Director's Resignation May Prompt FDA Criminal Investigations Overhaul
This article was originally published in The Tan Sheet
Executive Summary
The resignation of Terry Vermillion, the long-time head of FDA's Office of Criminal Investigations, will give the agency a chance to overhaul thoroughly the office.
You may also be interested in...
Better Intra-Agency Reviews Could Speed FDA Seizure, Injunction Decisions
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.
Better Intra-Agency Reviews Could Speed FDA Seizure, Injunction Decisions
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.
Better Intra-Agency Reviews Could Speed FDA Seizure, Injunction Decisions
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.